Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (71-80 of 349) with videos related to

Pageof 35
Sort By:
Drug Design, Development and Therapy|August 24, 2019
Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjectsSeol Ju Moon, Ji-Young Jeon, Kyungho Jang, et al.
Journal of Thrombosis and Haemostasis : JTH|February 6, 2026
A First-in-Human Study Assessing the Safety, Pharmacokinetics, and Pharmacodynamics of TU7710, a Recombinant Factor VIIa-Transferrin Fusion Protein, in Warfarin-Pretreated Healthy Male ParticipantsByungwook Kim, Jisoo Song, Jaegu Kang, et al.
Translational and Clinical Pharmacology|April 15, 2021
Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjectsJihyun Jung, Soyoung Lee, Jaeseong Oh, et al.
Drug Design, Development and Therapy|March 3, 2018
Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjectsYu Kyong Kim, Kwang-Hee Shin, Jeffrey Alderman, et al.
British Journal of Clinical Pharmacology|May 11, 2026
Safety, pharmacokinetics and pharmacodynamics of NXC736, a novel sphingosine-1-phosphate receptor modulatorWoo Kyung Chung, Heesun Kim, Yanghae Park, et al.
Healthcare Informatics Research|August 17, 2023
Exploring the Category and Use Cases on Digital Therapeutic MethodologiesSunhee An, Jieun Ko, Kyung-Sang Yu, et al.
Drug Design, Development and Therapy|November 22, 2017
Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trialsSeokuee Kim, SeungHwan Lee, Joo-Youn Cho, et al.
Drug Design, Development and Therapy|May 12, 2018
Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with JapaneseYewon Choi, Seonghae Yoon, Kyoko Matsumoto, et al.
Plos One|November 14, 2022
Efficacy and safety of a new ranibizumab biosimilar CKD-701 using a pro re nata treatment regimen in neovascular age-related macular degeneration: A phase 3 randomized clinical trialChang Ki Yoon, Jaeryung Oh, Kunho Bae, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 23, 2019
Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjectsDongseong Shin, Young Sil Eom, Suk Chon, et al.
Pageof 35

Showing results (71-80 of 349) with videos related to

Sort By:
Pageof 35
Drug Design, Development and Therapy|August 24, 2019
Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjectsSeol Ju Moon, Ji-Young Jeon, Kyungho Jang, et al.
Journal of Thrombosis and Haemostasis : JTH|February 6, 2026
A First-in-Human Study Assessing the Safety, Pharmacokinetics, and Pharmacodynamics of TU7710, a Recombinant Factor VIIa-Transferrin Fusion Protein, in Warfarin-Pretreated Healthy Male ParticipantsByungwook Kim, Jisoo Song, Jaegu Kang, et al.
Translational and Clinical Pharmacology|April 15, 2021
Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjectsJihyun Jung, Soyoung Lee, Jaeseong Oh, et al.
Drug Design, Development and Therapy|March 3, 2018
Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjectsYu Kyong Kim, Kwang-Hee Shin, Jeffrey Alderman, et al.
British Journal of Clinical Pharmacology|May 11, 2026
Safety, pharmacokinetics and pharmacodynamics of NXC736, a novel sphingosine-1-phosphate receptor modulatorWoo Kyung Chung, Heesun Kim, Yanghae Park, et al.
Healthcare Informatics Research|August 17, 2023
Exploring the Category and Use Cases on Digital Therapeutic MethodologiesSunhee An, Jieun Ko, Kyung-Sang Yu, et al.
Drug Design, Development and Therapy|November 22, 2017
Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trialsSeokuee Kim, SeungHwan Lee, Joo-Youn Cho, et al.
Drug Design, Development and Therapy|May 12, 2018
Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with JapaneseYewon Choi, Seonghae Yoon, Kyoko Matsumoto, et al.
Plos One|November 14, 2022
Efficacy and safety of a new ranibizumab biosimilar CKD-701 using a pro re nata treatment regimen in neovascular age-related macular degeneration: A phase 3 randomized clinical trialChang Ki Yoon, Jaeryung Oh, Kunho Bae, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 23, 2019
Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjectsDongseong Shin, Young Sil Eom, Suk Chon, et al.
Pageof 35